| Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues MY Li, L Li, Y Zhang, XS Wang Infectious diseases of poverty 9 (02), 23-29, 2020 | 1807 | 2020 |
| Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses Z Abdelrahman, M Li, X Wang Frontiers in immunology, 2309, 2020 | 522 | 2020 |
| A comprehensive immunologic portrait of triple-negative breast cancer Z Liu, M Li, Z Jiang, X Wang Translational oncology 11 (2), 311-329, 2018 | 232 | 2018 |
| Correlate tumor mutation burden with immune signatures in human cancers X Wang, M Li BMC immunology 20, 1-13, 2019 | 166 | 2019 |
| Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment Z Jiang, Z Liu, M Li, C Chen, X Wang EBioMedicine 42, 431-442, 2019 | 118 | 2019 |
| Cancer type-dependent correlations between TP53 mutations and antitumor immunity L Li, M Li, X Wang DNA repair 88, 102785, 2020 | 115 | 2020 |
| Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach M Li, Z Zhang, W Cao, Y Liu, B Du, C Chen, Q Liu, MN Uddin, S Jiang, ... Science of the Total Environment 764, 142810, 2021 | 110 | 2021 |
| Immunogenomics analysis reveals that TP53 mutations inhibit tumor immunity in gastric cancer Z Jiang, Z Liu, M Li, C Chen, X Wang Translational oncology 11 (5), 1171-1187, 2018 | 102 | 2018 |
| Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer H Lyu, M Li, Z Jiang, Z Liu, X Wang Computational and structural biotechnology journal 17, 1020-1030, 2019 | 98 | 2019 |
| ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer L Li, M Li, Z Jiang, X Wang Cells 8 (7), 678, 2019 | 92 | 2019 |
| Transcriptional landscape of human cancers M Li, Q Sun, X Wang Oncotarget 8 (21), 34534, 2017 | 86 | 2017 |
| Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment X Han, Q Wei, Y Lv, L Weng, H Huang, Q Wei, M Li, Y Mao, D Hua, X Cai, ... Molecular Therapy 30 (1), 327-340, 2022 | 66 | 2022 |
| An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles M Li, Z Zhang, L Li, X Wang Communications biology 3 (1), 505, 2020 | 66 | 2020 |
| The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression Z Zhang, L Li, M Li, X Wang Computational and structural biotechnology journal 18, 2438-2444, 2020 | 42 | 2020 |
| Identification of Transcriptional Markers and microRNA–mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor … MN Uddin, M Li, X Wang Cells 8 (9), 1054, 2019 | 39 | 2019 |
| HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers B Chen, L Li, M Li, X Wang Cellular Oncology 43, 877-888, 2020 | 36 | 2020 |
| Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription Y Liu, X Wang, W Li, Y Xu, Y Zhuo, M Li, Y He, X Wang, Q Guo, L Zhao, ... Oncogene 39 (45), 6893-6905, 2020 | 35 | 2020 |
| Exploration of the combination of PLK1 inhibition with immunotherapy in cancer treatment M Li, Z Liu, X Wang Journal of oncology 2018, 2018 | 32 | 2018 |
| Identification of transcriptional signatures of colon tumor stroma by a meta-analysis M Uddin, M Li, X Wang Journal of Oncology 2019, 2019 | 31 | 2019 |
| Predicting the epidemic trend of COVID-19 in China and across the world using the machine learning approach M Li, Z Zhang, S Jiang, Q Liu, C Chen, Y Zhang, X Wang medRxiv, 2020.03. 18.20038117, 2020 | 27 | 2020 |
